• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 3. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 4. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Secondary amines

7-Bromo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine (CAS No. 52333-31-0): A Versatile Heterocyclic Compound in Pharmaceutical Research

The 7-Bromo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine (CAS No. 52333-31-0) is a brominated heterocyclic compound that has garnered significant attention in pharmaceutical and medicinal chemistry research. This bicyclic structure combines pyridine and pyrazine moieties, making it a valuable scaffold for drug discovery. With the increasing demand for novel heterocyclic compounds in drug development, this molecule has emerged as a promising candidate for various therapeutic applications.

Chemically, 7-Bromo-1,2,3,4-tetrahydropyridopyrazine features a bromine atom at the 7-position, which significantly influences its reactivity and potential biological activity. The presence of this halogen atom makes the compound particularly useful in cross-coupling reactions, a topic that has seen growing interest in recent years due to its applications in creating complex molecular architectures. Researchers are actively exploring its potential in palladium-catalyzed reactions, which are frequently searched terms in synthetic chemistry databases.

One of the most searched questions in pharmaceutical chemistry is "how to modify heterocyclic compounds for better drug-like properties?" The 7-Bromo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine structure addresses this perfectly, as its core can be easily functionalized to improve pharmacokinetic properties. Recent studies have shown its potential as a precursor for CNS-active compounds, particularly in the development of neurological disorder treatments, a hot topic in current medical research.

The synthetic versatility of 7-Bromo-1,2,3,4-THP pyrazine (an alternative name that appears in many search queries) makes it valuable for creating diverse molecular libraries. In drug discovery, where "scaffold hopping" is a frequently searched concept, this compound serves as an excellent starting point for generating structurally novel bioactive molecules. Its balanced lipophilicity and potential for hydrogen bonding make it particularly interesting for kinase inhibitor development, another trending research area.

From a commercial perspective, the demand for high-purity 7-Bromo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine has been steadily increasing, as evidenced by growing search volumes for this compound across scientific procurement platforms. Suppliers often highlight its application in high-throughput screening and fragment-based drug design, two methodologies that dominate current pharmaceutical research strategies.

Recent advancements in AI-assisted drug discovery have brought renewed interest in compounds like 7-Bromo-1,2,3,4-tetrahydropyridopyrazine. Machine learning algorithms frequently identify such scaffolds as having high "druggability" potential, making this compound a subject of numerous computational chemistry studies. This aligns well with the growing number of searches for "computational prediction of bioactive compounds."

The stability and storage conditions of 7-Bromo-THP-pyrazine derivatives are common concerns among researchers, as reflected in frequent search queries. Proper handling under inert atmosphere and storage at controlled temperatures are recommended to maintain the compound's integrity, especially considering its potential sensitivity to light-induced bromine dissociation.

In the context of green chemistry, which has seen exponential growth in search interest, modifications of 7-Bromo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine using environmentally friendly protocols are being actively investigated. Researchers are particularly interested in developing catalyst-free reactions and microwave-assisted syntheses involving this scaffold, addressing the pharmaceutical industry's push toward sustainable practices.

Analytical characterization of 7-Bromo-1,2,3,4-tetrahydropyridopyrazine typically involves advanced techniques like LC-MS and NMR spectroscopy, topics that consistently rank high in scientific search engines. The compound's distinct spectral signatures make it an excellent model for method development in analytical chemistry laboratories.

Looking forward, the 7-Bromo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine scaffold is poised to play a significant role in addressing current challenges in drug discovery, particularly in the development of targeted therapies and precision medicine approaches. Its structural features align well with modern drug design paradigms that emphasize molecular specificity and reduced off-target effects.

For researchers interested in purchasing 7-Bromo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine (CAS 52333-31-0), it's important to verify the supplier's analytical data and purity specifications, as these factors significantly influence experimental outcomes. The compound is typically available in research quantities from specialty chemical providers catering to the pharmaceutical development sector.

In conclusion, 7-Bromo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine represents a versatile and valuable building block in modern medicinal chemistry. Its unique structural features, combined with growing interest in brominated heterocycles for drug discovery, ensure its continued relevance in pharmaceutical research. As the field moves toward more sophisticated drug design strategies, this compound will likely remain an important tool for chemists developing next-generation therapeutic agents.

• 503039-03-0(1,2-Ethanediamine, N-(5-bromo-2-pyridinyl)-N'-phenyl-)
• 1216000-02-0(5-Bromo-2-N-cyclopentylpyridine-2,3-diamine)
• 35808-40-3(1H,2H,3H,4H-pyrido[2,3-b]pyrazine)
• 168123-82-8(7-bromo-1H,2H,3H,4H-pyrido[2,3-b]pyrazine-2,3-dione)
• 1227075-63-9(7-bromo-1,2,3,4-tetrahydro-8-methyl-Pyrido[2,3-b]pyrazine)
• 957198-15-1(7-Bromo-1,2-dihydropyrido2,3-bpyrazin-3(4h)-one)
• 89415-54-3(5-Bromo-N2-methylpyridine-2,3-diamine)
• 1010422-25-9(2,3-Pyridinediamine, 5-bromo-N2-cyclopropyl-)
• 1227075-76-4(7-bromo-1,2,3,4-tetrahydro-6-methyl-Pyrido[2,3-b]pyrazine)
• 709652-84-6(7-Bromo-3,4-dihydropyrido2,3-bpyrazin-2(1H)-one)